Pulmonary and Critical Care Pharmacology

Principles of pulmonary pharmacology - receptors and target cells; autonomic innervation; mediators of inflammation; airway smooth muscle; cytokines in the Lung; inflammation; toxicology and environmental factors; pharmacology of conducting airways: beta-adrenoceptor agonists; drugs that inhibit phosphodiesterase; anticholinergic agents; corticosteroids; anti-inflammatory therapies other than corticosteroids; therapy for asthma directed against specific metabolites; stimulants, anti-tussive agents and mucolytics; adverse drug reaction; treatment of obstructive lung diseases - asthma, therapeutic principles; innovative asthma therapies and special problems; treatment of chronic obstructive pulmonary disease and bronchiectasis; treatment of cystic fibrosis; pharmacology of pulmonary embolic disease - treatment of pulmonary embolism; treatment of systemic critical illness and disordered breathing - pharmacology of acute lung injury, adult respiratory distress syndrome; pharmacology of systemic critical illness; treatment of disordered breathing; treatment of idiopathic lung diseases - treatment of idiopathic parenchymal lung diseases; rare disorders of the lung; special treatment modalities.